Literature DB >> 17555416

Review article: possible beneficial effects of coffee on liver disease and function.

I S H Cadden1, N Partovi, E M Yoshida.   

Abstract

BACKGROUND: Coffee is consumed by 50 percent of Americans every day. After oil, coffee is the second most valuable commodity in the world. In recent years a number of studies have suggested potential health risks associated with coffee consumption; however, the results are controversial. Whilst coffee has been reported to increase cardiovascular risk factors, other investigators have demonstrated its protective effects on diseases ranging from type 2 diabetes to Parkinson's disease. A number of investigators have focused their attention on the relationship between the consumption of coffee and liver disease. AIM: To examine the published literature to date in an attempt to establish the presence of an hepatoprotective effect of coffee.
METHODS: Using PubMed, we identified published studies and review articles relating to the effect of coffee consumption on diseases of the liver.
CONCLUSION: A number of studies have reported the beneficial effects of coffee on abnormal liver biochemistry, cirrhosis and hepatocellular carcinoma. At the present time the mechanism of this effect remains unclear as does the ''dose'' required to achieve these benefits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17555416     DOI: 10.1111/j.1365-2036.2007.03319.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  19 in total

1.  Coffee and liver - long way to go.

Authors:  Ajay K Duseja
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

2.  Coffee prevents CCl(4)-induced liver cirrhosis in the rat.

Authors:  Mario G Moreno; Enrique Chávez; Liseth R Aldaba-Muruato; José Segovia; Paula Vergara; Víctor Tsutsumi; Mineko Shibayama; Yadira Rivera-Espinoza; Pablo Muriel
Journal:  Hepatol Int       Date:  2011-01-25       Impact factor: 6.047

Review 3.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

Review 4.  Pathological roles of purinergic signaling in the liver.

Authors:  Byron P Vaughn; Simon C Robson; Geoffrey Burnstock
Journal:  J Hepatol       Date:  2012-06-16       Impact factor: 25.083

5.  Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project.

Authors:  Jessica L Petrick; Neal D Freedman; Barry I Graubard; Vikrant V Sahasrabuddhe; Gabriel Y Lai; Michael C Alavanja; Laura E Beane-Freeman; Deborah A Boggs; Julie E Buring; Andrew T Chan; Dawn Q Chong; Charles S Fuchs; Susan M Gapstur; John Michael Gaziano; Edward L Giovannucci; Albert R Hollenbeck; Lindsay Y King; Jill Koshiol; I-Min Lee; Martha S Linet; Julie R Palmer; Jenny N Poynter; Mark P Purdue; Kim Robien; Catherine Schairer; Howard D Sesso; Alice J Sigurdson; Anne Zeleniuch-Jacquotte; Jean Wactawski-Wende; Peter T Campbell; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-30       Impact factor: 4.254

6.  KASL Clinical Practice Guidelines: Management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2012-06-26

7.  Caffeine protects against alcoholic liver injury by attenuating inflammatory response and oxidative stress.

Authors:  Xiongwen Lv; Zhen Chen; Jun Li; Lei Zhang; Hongfeng Liu; Cheng Huang; Pengli Zhu
Journal:  Inflamm Res       Date:  2010-03-10       Impact factor: 4.575

8.  How does coffee prevent liver fibrosis? Biological plausibility for recent epidemiological observations.

Authors:  Jonathan A Dranoff; Jordan J Feld; Elise G Lavoie; Michel Fausther
Journal:  Hepatology       Date:  2014-05-27       Impact factor: 17.425

9.  Effect of competition bias in safety signal generation: analysis of a research database of spontaneous reports in France.

Authors:  Antoine Pariente; Paul Avillach; Francesco Salvo; Frantz Thiessard; Ghada Miremont-Salamé; Annie Fourrier-Reglat; Françoise Haramburu; Bernard Bégaud; Nicholas Moore
Journal:  Drug Saf       Date:  2012-10-01       Impact factor: 5.606

Review 10.  Association between caffeine consumption and nonalcoholic fatty liver disease: a systemic review and meta-analysis.

Authors:  Huafeng Shen; Andrea C Rodriguez; Ashok Shiani; Seth Lipka; Ghulamullah Shahzad; Ambuj Kumar; Paul Mustacchia
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.